DE/EN
  • Deutsch
  • English
  • About us
    • His­tory
    • Who we are
    • Man­age­ment
    • Found­a­tion
    • Super­vis­ory Board
    • Sci­entific Advis­ory Board
    • Sci­entific Advisors
  • Back­ground
  • Research
    • Pro­jects
    • Tech­no­lo­gies
    • Pub­lic­a­tions
  • Ser­vices
    • Gen­ome Editing
    • Human iPS cells
    • Meas­ure­ments to accom­pany (pre-)clinical studies
    • Reg­u­lat­ory services
  • Co-Oper­­a­­tions
  • News
  • Jobs
  • Con­tact
REPROGRAM - REFINE - REGENERATE REPROGRAM - REFINE - REGENERATE REPROGRAM - REFINE - REGENERATE REPROGRAM - REFINE - REGENERATE
  • About us
    • His­tory
    • Who we are
    • Man­age­ment
    • Found­a­tion
    • Super­vis­ory Board
    • Sci­entific Advis­ory Board
    • Sci­entific Advisors
  • Back­ground
  • Research
    • Pro­jects
    • Tech­no­lo­gies
    • Pub­lic­a­tions
  • Ser­vices
    • Gen­ome Editing
    • Human iPS cells
    • Meas­ure­ments to accom­pany (pre-)clinical studies
    • Reg­u­lat­ory services
  • Co-Oper­­a­­tions
  • News
  • Jobs
  • Con­tact

Archives

Author Archive for: "p564569"
Home » Archives for
Go-ahead for the optim­iz­a­tion of new immunotherapies
0
By
In News, Start
Posted 17. May 2022

Go-ahead for the optim­iz­a­tion of new immunotherapies

Fighting autoimmune diseases and cancer with human immune cells more efficiently: medicine is moving a step closer to this vision with new processes developed by ISAR Bioscience GmbH

READ MORE
Teamassist­ent (gn)
0
By
In Jobs
Posted 30. March 2022

Teamassist­ent (gn)

Wir suchen ab sofort einen Teamassistenten (gn) in Teilzeit (20-25 Stunden) als kompetente und motivierte Verstärkung unseres Teams.

READ MORE
0
By
In
Posted 22. March 2022

Our Tech­no­logy Platforms

READ MORE
Recept­ors and cel­lu­lar communication
0
By
In Services, Uncategorized
Posted 15. March 2022

Recept­ors and cel­lu­lar communication

Our group focuses on the mechanisms of activation and signaling of G‑protein coupled receptors (GPCR), and subsequent downstream events which lead to alterations in cell function.

READ MORE
New cel­lu­lar nano­world discovered
0
By
In News, Publications, Start
Posted 15. March 2022

New cel­lu­lar nano­world discovered

A research team led by Martin Lohse has now shown how a cell can process hundreds of signals simultaneously. The new results, published in the prestigious journal "Cell", will open up a [...]

READ MORE
Sci­ent­ist/­Post-doc – Immun­o­logy (gn)
0
By
In Jobs
Posted 15. March 2022

Sci­ent­ist/­Post-doc – Immun­o­logy (gn)

We are looking for Scientists/Post-doc to join our team (full-time position).

READ MORE
Labor­at­ory Assist­ant (gn) – Part-time (20h/week)
0
By
In Jobs
Posted 21. February 2022

Labor­at­ory Assist­ant (gn) – Part-time (20h/week)

Zur Verstärkung unseres Teams suchen wir zum 01.03.2022 eine/n Labormitarbeiter (gn).

READ MORE
Mil­lions in fund­ing for new ther­apy against Covid-19
0
By
In News, Start
Posted 12. January 2022

Mil­lions in fund­ing for new ther­apy against Covid-19

The German Federal Ministry of Education and Research (BMBF) has announced the winners in the competition for new therapies against Covid-19. At the forefront is the joint project of rnatics, a [...]

READ MORE
Neut­ral­iz­ing anti­bod­ies and T cells against SARS-CoV2 and mutants, espe­cially the delta mutant
0
By
In Diagnostics of SARS-CoV2 antibodies, Publications
Posted 20. September 2021

Neut­ral­iz­ing anti­bod­ies and T cells against SARS-CoV2 and mutants, espe­cially the delta mutant

We found that SARS-CoV-2 delta mutant antibody neutralisation was reduced compared to the Wuhan wild type (wt), …

READ MORE
Devel­op­ment of innov­at­ive peptides
0
By
In Publications
Posted 13. September 2021

Devel­op­ment of innov­at­ive peptides

for the treatment of various autoimmune diseases such as rheumatoid arthritis

READ MORE
1 2 3 4 5 6 7
page 1 of 7
  • +49 89 356 475 400
  • info@isarbioscience.de
NAVIGATION
  • About us
  • Back­ground
  • Research
  • Ser­vices
  • Co-Oper­­a­­tions
  • News
  • Jobs
  • Con­tact
© 2022 ISAR Bioscience. All rights reserved.
  • Cookie Set­tings
  • Pri­vacy Policy
  • Legal Inform­a­tion
  • DeutschDeutsch